CT beats fluoroscopy for Crohn's disease anomalies
CT can outperform fluoro-based enteroclysis, the current imaging standard for small bowel evaluation in patients with Crohn's disease, according to a study in the American Journal of Roentgenology.
CT can outperform fluoro-based enteroclysis, the current imaging standard for small bowel evaluation in patients with Crohn's disease, according to a study in the American Journal of Roentgenology.
The big advantage of CT enteroclysis is its ability to detect complications that exist outside normal parameters of the diagnosis and identification of Crohn's disease, according to principal investigator Dr. Johannes Sailer, a radiologist at the Medical University of Vienna.
Researchers evaluated with both techniques 50 symptomatic patients. Results were matched with surgery and follow-up (AJR 2005;185;1575-1581). CT enteroclysis proved better than conventional enteroclysis at detecting fistulae, abscesses, and conglomeration of small bowel loops. CT enteroclysis also proved equivalent to standard imaging in the detection of minimal mucosal changes.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
